Journal of Medicinal Chemistry p. 10272 - 10293 (2019)
Update date:2022-08-15
Topics:
Engelhardt, Harald
B?se, Dietrich
Petronczki, Mark
Scharn, Dirk
Bader, Gerd
Baum, Anke
Bergner, Andreas
Chong, Eugene
D?bel, Sandra
Egger, Georg
Engelhardt, Christian
Ettmayer, Peter
Fuchs, Julian E.
Gerstberger, Thomas
Gonnella, Nina
Grimm, Andreas
Grondal, Elisabeth
Haddad, Nizar
Hopfgartner, Barbara
Kousek, Roland
Krawiec, Mariusz
Kriz, Monika
Lamarre, Lyne
Leung, Joyce
Mayer, Moriz
Patel, Nitinchandra D.
Simov, Biljana Peric
Reeves, Jonathan T.
Schnitzer, Renate
Schrenk, Andreas
Sharps, Bernadette
Solca, Flavio
Stadtmüller, Heinz
Tan, Zhulin
Wunberg, Tobias
Zoephel, Andreas
McConnell, Darryl B.
The epidermal growth factor receptor (EGFR), when carrying an activating mutation like del19 or L858R, acts as an oncogenic driver in a subset of lung tumors. While tumor responses to tyrosine kinase inhibitors (TKIs) are accompanied by marked tumor shrinkage, the response is usually not durable. Most patients relapse within two years of therapy often due to acquisition of an additional mutation in EGFR kinase domain that confers resistance to TKIs. Crucially, oncogenic EGFR harboring both resistance mutations, T790M and C797S, can no longer be inhibited by currently approved EGFR TKIs. Here, we describe the discovery of BI-4020, which is a noncovalent, wild-type EGFR sparing, macrocyclic TKI. BI-4020 potently inhibits the above-described EGFR variants and induces tumor regressions in a cross-resistant EGFRdel19 T790M C797S xenograft model. Key was the identification of a highly selective but moderately potent benzimidazole followed by complete rigidification of the molecule through macrocyclization.
View MoreContact:732.938.2777
Address:5012 Industrial Road Farmingdale, NJ 07727
AllyChem Co., Ltd., Dalian, China(BBChem)
Contact:+86-411-62313318/62313328
Address:No.5 of Jinbin Road, Jinzhou New District, Dalian City, Liaoning Province, P.R.China
Springchem New Material Technology Co.,Limited
website:http://www.spring-chem.com
Contact:86-21-62885108
Address:602B, Building 1, No. 641, Tianshan Road
shanghai Tauto Biotech Co., Ltd
website:http://www.tautobiotech.com/en/index.htm
Contact:+86-21-51320588 ext. 8025
Address:No. 326, Aidisheng Rd , Zhangjiang Hi-tech Park, Shanghai , P.R.CHINA
Contact:86-931-8272767
Address:Room 602, No.461, Nanchang Road, Chengguan District, Lanzhou City, China PRC
Doi:10.1002/hlca.19800630832
(1980)Doi:10.1016/S0040-4039(01)92946-6
(1981)Doi:10.1021/ja01174a076
(1949)Doi:10.1016/j.bmcl.2010.08.025
(2010)Doi:10.3109/14756366.2015.1094469
(2016)Doi:10.1002/chem.201403734
(2014)